Scholar Rock Holding buy Jefferies Financial Group Inc.
Start price
25.10.23
/
50%
€8.55
Target price
25.10.24
€18.91
Performance (%)
67.25%
Price
03.05.24
€14.30
Summary
This prediction is currently active. With a performance of 67.25% the BUY prediction by Jefferies_Financial_ is a big success. This prediction currently runs until 25.10.24. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Scholar Rock Holding | 5.147% | 5.147% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Jefferies_Financial_ for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock Holding Co. (NASDAQ: SRRK) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for SRRK provided by MarketBeat